How is tricuspid regurgitation (TR) managed in patients with atrial septal defects (ASD)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 7, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Tricuspid Regurgitation in Patients with Atrial Septal Defects

In patients with atrial septal defects (ASD) and significant tricuspid regurgitation (TR), surgical ASD closure with concomitant tricuspid valve repair is strongly recommended when TR is moderate to severe, especially with symptoms or right heart enlargement. 1

Assessment of TR in ASD Patients

  • Mechanism of TR in ASD: Primarily functional due to right ventricular (RV) volume overload from left-to-right shunting, leading to tricuspid annular dilation and valve leaflet tethering
  • Diagnostic evaluation:
    • Echocardiography to assess TR severity, tricuspid valve anatomy, and right heart chamber enlargement
    • Measurement of right atrial area, RV size, and pulmonary artery pressures
    • Assessment of TR jet area and tricuspid annular dimensions

Management Algorithm Based on TR Severity

Mild TR with ASD:

  • ASD closure alone (device or surgical depending on ASD type) without tricuspid valve intervention
  • TR often improves spontaneously after ASD closure due to reduced RV volume overload 2

Moderate TR with ASD:

  • Without pulmonary hypertension (PA systolic pressure <44 mmHg):

    • ASD closure alone is reasonable, as TR often improves after correction 2
    • Follow closely for TR regression post-closure
  • With pulmonary hypertension (PA systolic pressure ≥44 mmHg):

    • Consider concomitant tricuspid valve repair at time of surgical ASD closure 1, 3
    • Pulmonary hypertension >60 mmHg predicts persistent TR after ASD closure 3

Severe TR with ASD:

  • Strong recommendation for surgical ASD closure with concomitant tricuspid valve repair 1
  • Tricuspid valve repair techniques include:
    • Annuloplasty ring placement
    • Kay's procedure (bicuspidization)
    • Creation of a "monocusp valve" in cases with mobile anterior leaflet 1

Special Considerations

Ebstein's Anomaly with ASD:

  • Surgical approach is preferred with repair of both the tricuspid valve and ASD closure 1
  • For mild to moderate TR in Ebstein's anomaly:
    • Device closure of ASD may be considered in carefully selected patients 4
    • Requires careful hemodynamic assessment with balloon test occlusion before permanent closure
    • Contraindicated if significant right-to-left shunting or elevated right heart pressures occur during test occlusion

Risk Factors for Persistent TR After ASD Closure:

  • Age ≥60 years
  • Right atrial end-diastolic area ≥10cm²/m²
  • Right ventricular systolic pressure ≥44 mmHg (strongest predictor)
  • Tricuspid annular plane systolic excursion ≤2.3 cm 5

Follow-up After Intervention

  • Echocardiographic assessment at 3-6 months and then annually
  • Monitor for:
    • Residual or recurrent TR
    • Right ventricular size and function
    • Residual shunting
    • Pulmonary artery pressures

Important Caveats

  • Isolated device closure of ASD in patients with severe TR may lead to persistent TR and progressive right heart failure
  • Persistent moderate/severe TR after ASD closure is associated with higher rates of adverse events including heart failure hospitalizations 5
  • In patients with Ebstein's anomaly, closing an ASD without addressing severe TR can lead to increased right heart pressures and decreased cardiac output 4
  • Tricuspid valve repair is preferred over replacement when feasible 1
  • For secundum ASDs with significant TR, consider surgical rather than percutaneous closure to allow for concomitant tricuspid valve repair 1

By addressing both the ASD and significant TR simultaneously, outcomes regarding morbidity, mortality, and quality of life are significantly improved compared to addressing only the ASD.

Related Questions

What is the pre and post operative management for an adult patient with an atrial septal defect (ASD) with left to right shunt, severe tricuspid regurgitation (TR), and atrial fibrillation?
What is the neurological risk assessment for a 21-year-old male with polytrauma (multiple injuries), history of hypovolemic shock, syncope, alcoholic hepatitis, and cardiac abnormalities, including possible Atrial Septal Defect (ASD), mild dilated Right Atrium (RA)/Right Ventricle (RV), moderate Tricuspid Regurgitation (TR), and moderate Pulmonary Arterial Hypertension (PAH), undergoing mandibular and maxilla fracture surgery?
How long should anticoagulant therapy be continued after a patient undergoes surgery for Atrial Septal Defect (ASD) with severe Tricuspid Regurgitation (TR) and left atrial appendage excision?
What is the difference in managing tricuspid regurgitation (TR) in patients with mitral stenosis (MS) versus atrial septal defect (ASD)?
What are the confounding factors to consider when assessing pallor in patients?
What are the causes of primary tricuspid regurgitation?
What is the recommended treatment for Helicobacter pylori (H. pylori) infection?
What is the management approach for a patient with elevated Low-Density Lipoprotein (LDL) cholesterol?
How should a patient with hepatic encephalopathy on lactulose (lactulose) 30mls three times a day (tds), Rifaximin (Rifaximin) 550mg twice a day (bd), thiamine (thiamine) 100mg twice a day (bd), Spironolactone (spironolactone) 75mg once a day (od), Furosemide (furosemide) 80mg in the morning and 40mg at lunchtime, be assessed and managed given persistent confusion and disorientation?
Can lytic lesions of bone in the spine be from benign processes?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.